Literature DB >> 7728105

Cataract extraction combined with trabeculotomy.

O Schwenn1, F Grehn.   

Abstract

Eyes with glaucomatous damage as well as eyes showing a clear elevation of intraocular pressure (IOP) to levels above normal frequently develop a permanent elevation of IOP after phacoemulsification or extracapsular cataract extraction, whereas the pressure in normal eyes usually decreases. In eyes with glaucomatous damage, we therefore combined cataract extraction with an antiglaucomatous operation, especially if a moderate pressure elevation was present: trabeculotomy and cataract extraction were performed in the same procedure. A corneal incision was used for phacoemulsification or extracapsular cataract extraction. The effects of the operation on the IOP and the visual acuity as well as the incidence of postoperative complications were investigated. In 44 operated eyes, the combination of cataract extraction and trabeculotomy proved to result in few complications and had a sufficient pressure-decreasing effect that continued throughout the 18 months of postoperative follow-up.

Entities:  

Mesh:

Year:  1995        PMID: 7728105

Source DB:  PubMed          Journal:  Ger J Ophthalmol        ISSN: 0941-2921


  3 in total

1.  Exit strategies in canaloplasty: intraoperative conversion into 180-degree trabeculotomy or 360-degree trabeculotomy in cases of unsuccessful catheterisation of Schlemm's canal: influence of degree of canal cleavage.

Authors:  Omar Alnahrawy; Gunnar Blumenstock; Focke Ziemssen; Peter Szurman; Martin Alexander Leitritz; Spyridon Dimopoulos; Bogomil Voykov
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-18       Impact factor: 3.117

2.  A prospective trial of phaco-trabeculotomy combined with deep sclerectomy versus phaco-trabeculectomy.

Authors:  Christoph Lüke; Thomas S Dietlein; Matthias Lüke; Walter Konen; Günter K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-15       Impact factor: 3.117

3.  [Combined glaucoma-cataract surgery].

Authors:  F Grehn; T Klink
Journal:  Ophthalmologe       Date:  2004-05-27       Impact factor: 1.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.